ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy
About this episode
Dr. Virginia F Borges and Dr. Ian E Krop discuss first-line and maintenance therapy for ER-positive, HER2-positive metastatic breast cancer.
Dr Virginia F Borges from the University of Colorado Anschutz Medical Campus in Aurora and Dr Ian E Krop from Yale Cancer Center in New Haven, Connecticut, review clinical research data and best practices guiding the selection of first-line and maintenance therapy for patients with ER-positive, HER2-positive metastatic breast cancer. CME information and select publications here .
More episodes of Breast Cancer Update
- HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making
- Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan
- Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway
- Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays
- Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan
- Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Explore listener stats, chart rankings, contacts and more on the Breast Cancer Update podcast page.